HCV Diagnosis and Management

Immediate Action: Reflex to HCV RNA Testing

• A reactive HCV antibody test must be followed immediately by HCV RNA testing to distinguish current infection from past resolved infection or false positivity, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
• Order HCV RNA testing (nucleic acid test/NAT) on the same blood sample used for the initial antibody test whenever possible, without requiring a second venipuncture, according to the Centers for Disease Control and Prevention 1, 4

Interpretation Based on HCV RNA Results

If HCV RNA is Detected (Positive):

• This confirms current HCV infection requiring linkage to care and treatment, as stated by the Centers for Disease Control and Prevention 1, 3, 5
• Provide appropriate counseling about transmission prevention, alcohol avoidance, and vaccination against hepatitis A and B, as recommended by the Centers for Disease Control and Prevention 6, 7
• Link patient to specialist care for antiviral therapy evaluation, according to the Centers for Disease Control and Prevention 5
• Before initiating antiviral therapy, retest HCV RNA on a subsequent blood sample to confirm viremia, as recommended by the Centers for Disease Control and Prevention 5

If HCV RNA is Not Detected (Negative):

• This indicates either past resolved HCV infection or false-positive antibody result, as stated by the Centers for Disease Control and Prevention 1, 3, 5
• No further action required in most cases, according to the Centers for Disease Control and Prevention 5
• If distinction between true past infection and false positivity is desired, test with a different FDA-approved HCV antibody assay (different platform/antigens reduce likelihood of repeated false positivity), as recommended by the Centers for Disease Control and Prevention 1, 8

Special Circumstances Requiring Modified Approach

Recent Exposure (Within Past 6 Months):

• Repeat HCV RNA testing is recommended even if initial RNA is negative, as antibodies may be present before viremia is detectable, according to the Centers for Disease Control and Prevention 1, 9, 8
• Alternatively, perform follow-up HCV antibody testing to demonstrate seroconversion, as recommended by the Centers for Disease Control and Prevention 1, 9

Immunocompromised Patients:

• Consider HCV RNA testing even with negative antibody, as antibody response may be blunted, according to the Centers for Disease Control and Prevention 1, 9
• HCV RNA testing should be considered the primary diagnostic modality in this population, as stated by the Centers for Disease Control and Prevention 1

Clinical Evidence of HCV Disease:

• Repeat HCV RNA testing if initial RNA is negative but clinical suspicion remains high (elevated transaminases, liver disease symptoms), as recommended by the Centers for Disease Control and Prevention 1, 8

Critical Pitfalls to Avoid

• Never report a reactive HCV antibody as "positive for hepatitis C" without RNA confirmation - this represents only presumptive infection, as stated by the Centers for Disease Control and Prevention 5

Laboratory Reporting Requirements

• Reactive HCV antibody and positive HCV RNA results are nationally notifiable conditions requiring reporting to health departments per local/state regulations, according to the Centers for Disease Control and Prevention 1, 3, 8
• Reports should specify whether testing indicates acute hepatitis C or past/present infection, as recommended by the Centers for Disease Control and Prevention 1, 3